Mutant SF3B1 promotes PDAC malignancy through TGF-β resistance
P. Simmler, T. Mengis, K. Van-Lehmann, A. Khales, T. Thomas, G. Rätsch, M. Stoffel, G. Schwank
This study shows that SF3B1K700E mutation in PDAC enhances tumor aggressiveness when combined with KRAS and p53 mutations by promoting TGF-β resistance.
bioRxiv · Jun 16, 2022Cancer Biology